These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13130947)

  • 21. [Comparative study on hemolytic toxicity of trifluoroacetoprimaquine and primaquine in rabbits].
    Shi X; Zhan C; Ha S; Yiao J
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(3):218-20. PubMed ID: 7867160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primaquine and travelers from the Arab world. A report and recommendations].
    Menéndez Capote R; Caña Lugo C; Fernández Núñez A
    Rev Cubana Med Trop; 1995; 47(3):221-3. PubMed ID: 9813483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes.
    KELLERMEYER RW; CARSON PE; SCHRIER SL; TARLOV AR; ALVING AS
    J Lab Clin Med; 1961 Nov; 58():715-24. PubMed ID: 14454971
    [No Abstract]   [Full Text] [Related]  

  • 24. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
    BREWER GJ; TARLOV AR; ALVING AS
    JAMA; 1962 May; 180():386-8. PubMed ID: 13872968
    [No Abstract]   [Full Text] [Related]  

  • 25. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
    Bolchoz LJ; Morrow JD; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2002 Oct; 303(1):141-8. PubMed ID: 12235244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemolytic effect of primaquine V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
    Dern RJ; Beutler E; Alving AS
    J Lab Clin Med; 1981 Jun; 97(6):750-9. PubMed ID: 7229509
    [No Abstract]   [Full Text] [Related]  

  • 27. Biochemical and genetic aspects of primaquine-sensitive hemolytic anemia.
    ALVING AS; KELLERMEYER RW; TARLOV A; SCHRIER S; CARSON PE
    Ann Intern Med; 1958 Aug; 49(2):240-8. PubMed ID: 13571815
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
    Beutler E; Duparc S;
    Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
    Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consideration of ethics in primaquine therapy against malaria transmission.
    Baird JK; Surjadjaja C
    Trends Parasitol; 2011 Jan; 27(1):11-6. PubMed ID: 20846906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New use of primaquine for malaria].
    Oliver M; Simon F; de Monbrison F; Beavogui AH; Pradines B; Ragot C; Moalic JL; Rapp C; Picot S
    Med Mal Infect; 2008 Apr; 38(4):169-79. PubMed ID: 18395381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Haemolysis due to primaquine in 3 cases].
    Zhang ZY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):40. PubMed ID: 16866141
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of vivax malaria with acute hemolysis from treatment of chloroquine combined with primaquine].
    Sun XD; Wang J; Wei C
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):195, 200. PubMed ID: 23072134
    [No Abstract]   [Full Text] [Related]  

  • 35. Methemoglobin incites primaquine toxicity through single-electron oxidation and modification.
    Balaji SN; Trivedi V
    J Basic Clin Physiol Pharmacol; 2013; 24(2):105-14. PubMed ID: 23412873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
    Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
    Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primaquine revisited six decades after its discovery.
    Vale N; Moreira R; Gomes P
    Eur J Med Chem; 2009 Mar; 44(3):937-53. PubMed ID: 18930565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primaquine-induced methemoglobinaemia].
    Jordán de Luna C; Palomo Navarro M; Pérez Cebrián M; Poveda Andrés JL
    Farm Hosp; 2011; 35(5):278-9. PubMed ID: 21703895
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on structure-activity relationships of hemolytic toxicity of primaquine derivatives].
    Ni YC; Xu YQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(3):173-7. PubMed ID: 1959168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.